CAR-T cell therapy has demonstrated remarkable success in treating hematologic malignancies and is now expanding into solid tumors. On June 1, 2025, The Lancet published positive results from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback